Skip to main content
Bioera logo

Bioera — Investor Relations & Filings

Ticker · BIE ISIN · IT0005516130 LEI · 815600CE609AFE44D992 XMIL Manufacturing
Open in API
Filings indexed 558 across all filing types
Latest filing 2020-03-23 Share Issue/Capital Cha…
Country IT Italy
Listing XMIL BIE

About Bioera

https://bioera.it/en/

Bioera S.p.A. is a company specializing in the production and distribution of natural and organic products. Its core business involves the development and marketing of a diverse portfolio that includes organic food, traditional food products, natural cosmetics, herbal remedies, and food supplements. The company focuses on providing consumers with products derived from natural sources, catering to the health and wellness market.

Recent filings

Filing Released Lang Actions
Bioera SpA - Approvate modifiche al contratto di investimento sottoscritto con Negma Group Limited lo scorso 25 luglio 2019
Share Issue/Capital Change Classification · 1% confidence The document is a press release ("COMUNICATO STAMPA") from Bioera S.p.A. dated March 23, 2020. The core content announces the approval of modifications to an existing investment contract involving the issuance of warrants (Warrant A and Warrant B) and subsequent capital increases required to service these warrants. This involves changes to the capital structure and financing terms. This clearly falls under the category of updates on company fundraising, financing activities, or capital structure changes. Therefore, the appropriate classification is Capital/Financing Update (CAP). It is not a full annual report (10-K), an earnings release (ER), or a simple dividend notice (DIV).
2020-03-23 Italian
Bioera SpA - calendario finanziario 2020
Report Publication Announcement Classification · 1% confidence The document is titled "Calendario finanziario 2020" (Financial Calendar 2020) and is issued as a "COMUNICATO STAMPA" (Press Release). It explicitly lists future dates for key corporate events, such as the Board meeting for approving the 2019 financial statements, the Shareholders' Meeting for approval, and the Board meeting for the semi-annual report. This document is announcing the schedule of future corporate events and reports, rather than being one of the reports itself (like 10-K, IR, or ER). Since it is an announcement about the publication schedule of other reports, it fits best under Report Publication Announcement (RPA). The document length is short (1972 chars), supporting the RPA classification over the full report classification.
2020-01-30 Italian
Bioera SpA - Accordo transattivo con Idea Team s.r.l.
Regulatory Filings Classification · 1% confidence The document is titled "COMUNICATO STAMPA" (Press Release) and announces a settlement agreement ("Accordo transattivo") between Bioera S.p.A. and Idea Team S.r.l. regarding the termination of ongoing legal disputes and the payment schedule for the settlement amount. This type of announcement, detailing a significant legal resolution and financial commitment, is a specific corporate event disclosure. It is not a full annual report (10-K), an earnings release (ER), or a quarterly report (IR). Since it deals with a significant legal matter and its resolution, it aligns best with the 'Legal Proceedings Report' (LTR) category, which covers updates on significant lawsuits or regulatory actions. Although it is a press release, the core content is the resolution of a legal matter, making LTR more specific than the general 'Regulatory Filings' (RNS). The document length (6533 chars) is substantial enough to contain the details of the settlement, not just a brief announcement of a report's publication.
2020-01-11 Italian
Bioera SpA - Accordo per la cessione della quota di partecipazione del Gruppo in Meditalia S.r.l.
M&A Activity Classification · 1% confidence The document is titled "COMUNICATO STAMPA" (Press Release) and details a significant corporate transaction: the agreement by Bioera S.p.A.'s subsidiary to sell its stake in Meditalia S.r.l.'s medical technology division (Spin-off) to IGEA Pharma N.V. This is an announcement regarding a major corporate action involving the sale of assets/subsidiaries, which falls under corporate financing or M&A activity. Since the document explicitly describes the terms of the acquisition/sale, the consideration (new IGEA shares), and the conditions precedent, it is a specific corporate transaction announcement. The closest fit among the provided codes is 'TAR' (M&A Activity). It is not a standard regulatory report (10-K, IR, ER) but a specific business development announcement.
2019-11-22 Italian
Bioera SpA - statuto
Regulatory Filings Classification · 1% confidence The document text provided is titled "STATUTO" (Statute/Bylaws) and contains articles detailing the company's name ("Bioera S.p.A."), registered office, duration, corporate purpose, capital structure (including share details and past capital increases related to warrants and convertible bonds), rules for shareholder meetings (convening, voting, quorums), and the composition and election process for the Board of Directors (Consiglio di Amministrazione). This content is characteristic of a company's foundational governing document, which is typically filed as part of incorporation or significant corporate governance updates. Since it is not a periodic financial report (10-K, IR, ER) or a specific transaction announcement (M&A, DIV), and it deals extensively with governance structure and capital rules, it most closely aligns with Governance Information (CGR) or potentially a foundational document that might be filed under a general regulatory category if a more specific one doesn't exist. Given the detailed governance and structural rules, CGR is the best fit among the provided options, although it is essentially the company's Articles of Association.
2019-11-21 Italian
Bioera - Comunicazione di variazione del capitale sociale
Share Issue/Capital Change Classification · 1% confidence The document is titled "Comunicato Stampa" (Press Release) and its subject is "Comunicazione di variazione del capitale sociale" (Communication of change in share capital). It details the increase in the number of shares following the conversion of convertible bonds and presents the updated share capital structure and shareholder breakdown. This directly relates to changes in the company's capital structure and share count, which aligns with the definition of 'Share Issue/Capital Change' (SHA). Although it is a press release, the core content is a formal notification of a capital structure change, making SHA more specific than a general Regulatory Filing (RNS) or Report Publication Announcement (RPA). The document length (4529 chars) is substantial enough to contain the details rather than just announcing an attachment.
2019-11-20 Italian

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.